abstract |
Ophthalmically acceptable compositions used in arresting the development of macular degeneration, retinopathy, glaucoma, eyelid disorders, corneal disease, or uveitis are disclosed. The compositions comprise a pharmaceutically acceptable carrier or diluent and at least one compound having the formula: n nwherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are as defined herein. |